Dysplasia-Carcinoma Transition Specific Transcripts in Colonic Biopsy Samples

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Galamb, Orsolya ^a,b   Wichmann, Barnabás ^a,b   Sipos, Ferenc ^a   Spisák, Sándor ^a,b   Krenács, Tibor ^a   Tóth, Kinga ^a   Leiszter, Katalin ^a   Kalmár, Alexandra ^a   Tulassay, Zsolt ^a,b   Molnár, Béla ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE;

ARTICLE; CANCER GRADING; COLON BIOPSY; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DYSPLASIA; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ADENOMA; CARCINOMA; CARCINOMA, TRANSITIONAL CELL; COLON; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERPLASIA; TISSUE ARRAY ANALYSIS;

EID: 84869132705     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048547     Document Type: Article

References (39)

1. Bingham S, Riboli E, (2004) Diet and cancer-the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer 4: 206-215.
2. Kim HJ, Yu MH, Kim H, Byun J, Lee C, (2008) Noninvasive molecular biomarkers for the detection of colorectal cancer. BMB Rep 41: 685-692.
3. Kwon HC, Kim SH, Roh MS, Kim JS, Lee HS, et al. (2004) Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancer. Dis Col Rect 47: 141-152.
4. Bertucci F, Salas S, Eysteries S, Nasser V, Finetti P, et al. (2004) Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 23: 1377-1391.
5. Birkenkamp-Demtroder K, Christensen LL, Olesen SH, Frederiksen CM, Laiho P, et al. (2002) Gene expression in colorectal cancer. Cancer Res 62: 4352-4363.
6. Williams NS, Gaynor RB, Scoggin S, Verma U, Gokaslan T, et al. (2003) Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res 9: 931-946.
7. Li M, Lin YM, Hasegawa S, Shimokawa T, Murata K, et al. (2004) Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol 24: 305-312.
8. Frederiksen CM, Knudsen S, Laurberg S, Ørntoft TF, (2003) Classification of Dukes' B and C colorectal cancers using expression arrays. J Cancer Res Clin Oncol 129: 263-271.
9. Birkenkamp-Demtroder K, Olesen SH, Sørensen FB, Laurberg S, Laiho P, et al. (2005) Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 54: 374-384.
10. Chiu ST, Hsieh FJ, Chen SW, Chen CL, Shu HF, et al. (2005) Clinicopathologic correlation of up-regulated genes identified using cDNA microarray and real-time reverse transcription-PCR in human colorectal cancer. Cancer Epidemiol Biomarkers Prev 14: 437-443.
11. Wang Y, Jatkoe T, Zhang Y, Mutch MG, Talantov D, (2004) Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol 22: 1564-1571.
12. Galamb O, Györffy B, Sipos F, Spisák S, Németh AM, et al. (2008) Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature. Dis Markers 25: 1-16.
13. Galamb O, Sipos F, Solymosi N, Spisák S, Krenács T, et al. (2008) Diagnostic mRNA expression patterns of inflamed, benign, and malignant colorectal biopsy specimen and their correlation with peripheral blood results. Cancer Epidemiol Biomarkers Prev 17: 2835-2845.
14. Galamb O, Spisák S, Sipos F, Tóth K, Solymosi N, et al. (2010) Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor. Br J Cancer 102: 765-773.
15. Mikeska T, Dobrovic A, (2009) Validation of a primer optimisation matrix to improve the performance of reverse transcription - quantitative real-time PCR assays. BMC Res Notes 2: 112.
16. Tumor Analysis Best Practices Working Group (2004) Expression profiling-best practices for data generation and interpretation in clinical trials. Nat Rev Genet 5: 229-237.
17. Han M, Liew CT, Zhang HW, Chao S, Zheng R, et al. (2008) Novel blood-based, five-gene biomarker set for the detection of colorectal cancer. Clin Cancer Res 14: 455-460.
18. Raychaudhuri S, Stuart JM, Altman RB (2000) Principal components analysis to summarize microarray experiments: application to sporulation time series. Pac Symp Biocomput 455-466.
19. McLachlan GJ (2004) Discriminant analysis and statistical pattern recognition. In: Wiley Series in Probability and Statistics. New York: Wiley-Interscience. 1-50.
20. Sabates-Bellver J, Van der Flier LG, de Palo M, Cattaneo E, Maake C, et al. (2007) Transcriptome profile of human colorectal adenomas. Mol Cancer Res 5: 1263-1275.
21. Matsuyama T, Ishikawa T, Mogushi K, Yoshida T, Iida S, et al. (2010) MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer. Int J Cancer 127: 2292-2299.
22. Streit S, Michalski CW, Erkan M, Friess H, Kleeff J, (2009) Confirmation of DNA microarray-derived differentially expressed genes in pancreatic cancer using quantitative RT-PCR. Pancreatology 9: 577-582.
23. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, et al. (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329: 1977-1981.
24. Zisman TL, Rubin DT, (2008) Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol 14: 2662-2669.
25. Ladanyi A, Sipos F, Szoke D, Galamb O, Molnar B, et al. (2006) Laser microdissection in translational and clinical research. Cytometry A 69: 947-960.
26. Croner RS, Foertsch T, Brueckl WM, Guenther K, Siebenhaar R, et al. (2005) Common denominator genes that distinguish colorectal carcinoma from normal mucosa. Int J Colorectal Dis 20: 353-362.
27. Sugiyama Y, Farrow B, Murillo C, Li J, Watanabe H, et al. (2005) Analysis of differential gene expression patterns in colon cancer and cancer stroma using microdissected tissues. Gastroenterology 128: 480-486.
28. Notterman DA, Alon U, Sierk AJ, Levine AJ, (2001) Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 61: 3124-3130.
29. Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, et al. (2002) Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94: 513-521.
30. Wen Y, Giardina SF, Hamming D, Greenman J, Zachariah E, et al. (2006) GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1. Clin Cancer Res 12: 5951-5959.
31. Van der Flier LG, Sabates-Bellver J, Oving I, Haegebarth A, De Palo M, et al. (2007) The Intestinal Wnt/TCF Signature. Gastroenterology 132: 628-632.
32. Itoh Y, Joh T, Tanida S, Sasaki M, Kataoka H, et al. (2005) IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells. Cytokine 29: 275-282.
33. Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, et al. (2009) Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung. Cancer Sci 100: 248-254.
34. Kobayashi K, Ohnishi A, Promsuk J, Shimizu S, Kanai Y, et al. (2008) Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells. Neurosurgery 62: 493-503.
35. Junker N, Johansen JS, Andersen CB, Kristjansen PE, (2005) Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer. Lung Cancer 48: 223-231.
36. Landvik NE, Hart K, Skaug V, Stangeland LB, Haugen A, et al. (2009) A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer. Carcinogenesis 30: 1186-1192.
37. Lurje G, Hendifar AE, Schultheis AM, Pohl A, Husain H, et al. (2009) Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer. Pharmacogenet Genomics 19: 95-102.
38. Namkoong H, Shin SM, Kim HK, Ha SA, Cho GW, et al. (2006) The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein. BMC Cancer 6: 74.
39. Doll D, Keller L, Maak M, Boulesteix AL, Siewert JR, et al. (2010) Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival. Int J Colorectal Dis 25: 573-581.